SCHEMBL257384

SCHEMBL257384

CCn1cccc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL257387 0.80
SCHEMBL19441242 0.77
SCHEMBL2058601 0.77
SCHEMBL1276978 0.77 ALDH1A1 (0.47)
SCHEMBL9664699 0.75 EEF2K (0.44)
SCHEMBL18433170 0.73 EEF2K (0.46)
SCHEMBL12301200 0.73 EEF2K (0.46)
SCHEMBL28235966 0.73 EEF2K (0.46)
SCHEMBL30517367 0.73 EEF2K (0.46)
SCHEMBL4686017 0.73 BRD4 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108690217-B Carbon fiber recycling composition and method 波音公司 2022-07-15 CN claimed
CN-109312073-A The preparation method of poly- (aryl ether sulfone) polymer and polymer composition and product comprising it 索尔维特殊聚合物美国有限责任公司 2019-02-05 CN claimed
CN-102050806-A Method for preparing product containing 5-hydroxymethyl furfural from lignocellulose XUE LI 2011-05-11 CN claimed
US-20230312524-A1 ALPHA1A-ADRENERGIC RECEPTOR AGONISTS AND METHODS OF USE CURASEN THERAPEUTICS, INC. 2023-10-05 US disclosed
CN-115699387-A Nonaqueous electrolyte storage element and method for manufacturing same 株式会社杰士汤浅国际 2023-02-03 CN disclosed
CN-108690217-B Carbon fiber recycling composition and method 波音公司 2022-07-15 CN disclosed
WO-2021212039-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2021-10-21 WO disclosed
WO-2021126693-A1 GEM-DISUBSTITUTED PIPERIDINE MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2021-06-24 WO disclosed
US-20200247812-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE INTEGRAL BIOSCIENCES PRIVATE LTD (IN) 2020-08-06 US disclosed
WO-2020015964-A1 PHOTO-CURABLE RESIN COMPOSITION FOR 3D PRINTING CLARIANT INTERNATIONAL LTD (CH) 2020-01-23 WO disclosed
CN-109563082-A Magnetic resonance imaging compound, wherein mesosome, magnetic resonance imaging agent and application and magnetic resonance imaging method employing 北京市神经外科研究所 2019-04-02 CN disclosed
US-20090048223-A1 Sulfonamide compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-02-19 US disclosed
EP-1567518-B1 OXIME ESTER PHOTOINITIATORS WITH HETEROAROMATIC GROUPS CIBA HOLDING INC (CH) 2009-01-14 EP disclosed
EP-1932841-A1 SULFONAMIDE COMPOUND Asahi Kasei Pharma Corporation (JP) 2008-06-18 EP disclosed
CN-101156275-A Electrolyte composition for photoelectric converter and photoelectric converter using the same NIPPON KAYAKU KK (JP) 2008-04-02 CN disclosed
CN-101142643-A Electrochemical cell SII MICRO PARTS LTD (JP) 2008-03-12 CN disclosed
US-20070179127-A1 Sulfonamide compound ASAHI KASEI PHARMA CORPORATION (JP) 2007-08-02 US disclosed
WO-2004052847-A2 TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2004-06-24 WO disclosed
EP-0248393-B1 METHOD FOR THE PREPARATION OF ACYLATED HETEROAROMATICS AT ZEOLITHIC CATALYSTS BASF Aktiengesellschaft (DE) 1991-08-07 EP disclosed
EP-0248393-A1 Method for the preparation of acylated heteroaromatics at zeolithic catalysts BASF Aktiengesellschaft (DE) 1987-12-09 EP disclosed